DE3582781D1 - Fibrinolyse verstaerkendes mittel. - Google Patents

Fibrinolyse verstaerkendes mittel.

Info

Publication number
DE3582781D1
DE3582781D1 DE8585402134T DE3582781T DE3582781D1 DE 3582781 D1 DE3582781 D1 DE 3582781D1 DE 8585402134 T DE8585402134 T DE 8585402134T DE 3582781 T DE3582781 T DE 3582781T DE 3582781 D1 DE3582781 D1 DE 3582781D1
Authority
DE
Germany
Prior art keywords
fibrinolysis
reinforcing agent
reinforcing
agent
fibrinolysis reinforcing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585402134T
Other languages
English (en)
Inventor
Yoshikuni Tamao
Ryoji Kikumoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Kasei Corp
Original Assignee
Mitsubishi Kasei Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Kasei Corp filed Critical Mitsubishi Kasei Corp
Application granted granted Critical
Publication of DE3582781D1 publication Critical patent/DE3582781D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8585402134T 1984-11-06 1985-11-06 Fibrinolyse verstaerkendes mittel. Expired - Fee Related DE3582781D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59233567A JPS61112018A (ja) 1984-11-06 1984-11-06 線溶増強剤

Publications (1)

Publication Number Publication Date
DE3582781D1 true DE3582781D1 (de) 1991-06-13

Family

ID=16957092

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585402134T Expired - Fee Related DE3582781D1 (de) 1984-11-06 1985-11-06 Fibrinolyse verstaerkendes mittel.

Country Status (10)

Country Link
US (1) US5141947A (de)
EP (1) EP0181267B1 (de)
JP (1) JPS61112018A (de)
AU (1) AU581469B2 (de)
CA (1) CA1269617A (de)
DE (1) DE3582781D1 (de)
DK (1) DK171840B1 (de)
IL (1) IL76883A (de)
NZ (1) NZ213982A (de)
ZA (1) ZA858385B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250720A (en) * 1987-06-05 1993-10-05 The Dupont Merck Pharmaceutical Company Intermediates for preparing peptide boronic acid inhibitors of trypsin-like proteases
US5242904A (en) * 1987-06-05 1993-09-07 The Dupont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
US5187157A (en) * 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
DE3804600A1 (de) * 1988-02-13 1989-08-24 Basf Ag Mischung aus einer thrombolytisch wirkenden und einer antithrombotischen substanz
GB8822147D0 (en) * 1988-09-21 1988-10-26 Ciba Geigy Ag Pharmaceutically active combination
DE3943241A1 (de) * 1989-12-22 1991-06-27 Schering Ag Thrombolytisch wirkendes kombinationspraeparat
US5506241A (en) * 1992-03-18 1996-04-09 Mitsubishi Chemical Corporation Argatroban preparations for ophthalmic use
US5371091A (en) * 1992-08-31 1994-12-06 Bristol-Myers Squibb Company Heteroaromatic amine thrombin inhibitors
JPH06219948A (ja) * 1993-01-25 1994-08-09 Mitsubishi Kasei Corp 抗トロンビン剤及びその製造方法
US5840733A (en) * 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
EP1109579B1 (de) * 1998-09-03 2005-12-07 BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG UND ZUM VERTRIEB VON PHARMAKA mbh Verwendung von tgf-beta inhibitoren zur behandlung von cerebralen krankheiten
WO2000054804A1 (en) * 1999-03-16 2000-09-21 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Und Zum Vertrieb Von Pharmaka Mbh Use of tgf-beta inhibitors for treating cerebral disorders
WO2003080061A1 (en) * 2002-03-21 2003-10-02 Dana-Farber Cancer Institute, Inc. Inhibition of cell death responses induced by oxidative stress
CN100467022C (zh) * 2007-04-13 2009-03-11 天津市炜杰科技有限公司 21(s)阿加曲班的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE786788A (fr) * 1971-07-27 1973-01-26 Rhone Poulenc Sa Nouvelle enzyme thrombolytique et sa preparation par fermentation d'un streptomyces
US3919414A (en) * 1973-08-29 1975-11-11 Abbott Lab Accelerating the lysis of blood clots
US4073916A (en) * 1974-11-08 1978-02-14 Mitsubishi Chemical Industries Limited N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
NL7512637A (nl) * 1974-11-08 1976-05-11 Mitsubishi Chem Ind Werkwijze ter bereiding van een geneesmiddel, het aldus gevormde geneesmiddel en werkwijze voor de bereiding van actieve component.
US4258192A (en) * 1977-12-16 1981-03-24 Mitsubishi Chemical Industries Limited N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
IE48623B1 (en) * 1978-08-31 1985-03-20 Mitsubishi Chem Ind Alpha-(n-arylsulfonyl-l-argininamides,processes for their preparation and pharmaceutical compositions containing these substances
IT1170913B (it) * 1981-04-23 1987-06-03 Manetti & Roberts Italo Brit Procedimento per la produzione di un principio attivo fibrinolitico vasale prodotto enzimatico specifico angiochinasi cosi' ottenuto e sue applicazioni farmaceutiche

Also Published As

Publication number Publication date
AU4920685A (en) 1986-05-15
AU581469B2 (en) 1989-02-23
EP0181267A2 (de) 1986-05-14
JPH0114884B2 (de) 1989-03-14
IL76883A (en) 1991-03-10
ZA858385B (en) 1987-06-24
DK508485D0 (da) 1985-11-04
EP0181267B1 (de) 1991-05-08
EP0181267A3 (en) 1989-02-22
US5141947A (en) 1992-08-25
DK508485A (da) 1986-05-07
NZ213982A (en) 1989-06-28
CA1269617A (en) 1990-05-29
JPS61112018A (ja) 1986-05-30
DK171840B1 (da) 1997-06-30

Similar Documents

Publication Publication Date Title
DE3585575D1 (de) Blutstillendes mittel.
IT8419374A0 (it) Agente antibroncopneumopatico.
ATE70529T1 (de) Schimmelbekaempfungsmittel.
NO854540L (no) Tynnplatekonstruksjon.
NO852404L (no) Doerkonstruksjon.
DE3583995D1 (de) Mischventilaggregat.
DE3581430D1 (de) Detergens.
DE3576268D1 (de) Hoergeraet.
ATE41922T1 (de) Alkylsulfonamidophenylalkylamine.
DE3581091D1 (de) Anti-karies- oder anti-periodontitismittel.
DE3486240D1 (de) Fungizide Mittel.
DE3581707D1 (de) Neigungsmesser.
NL191847C (nl) Verbindingsconstructie.
DE3582781D1 (de) Fibrinolyse verstaerkendes mittel.
FI860904A0 (fi) Ny amidinfoerening.
DE3579915D1 (de) Antineoplastisches mittel.
DE3577322D1 (de) Verdickungsmittel.
FI854538A0 (fi) Elektrisk drivanordning foer hiss.
DE3483478D1 (de) Schalter.
DE3577708D1 (de) Diphenylhexafluorpropanabkoemmlinge.
FI841777A (fi) Kromogeniska 3,3-bisindolyl-4- azaftalider.
DE3579862D1 (de) Mikrorechner.
DE3574867D1 (de) Aminokarnitine.
DE3577108D1 (de) Modifizierte urokinase-zusammensetzung.
NO168493C (no) Bygningsblokk.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee